China Closes In on US in Biotech as AI Reshapes Drug Development Race
The United States’ long-held dominance in the global biotechnology sector is facing an unprecedented challenge from China, with artificial intelligence acting as a powerful accelerant in the race to develop new drugs. China’s growing strength in AI-driven research mirrors its advances in other deep-tech sectors including semiconductors and robotics.